Google
The Houston Aortic Symposium: Frontiers in Cardiovascular Diseases, the Ninth in the Series

register

The Houston Aortic Symposium: Frontiers in Cardiovascular Diseases, the Ninth in the Series
Mar 3-5, 2016

Interventional Cardiology 2016: 31st Annual International Symposium

register

Interventional Cardiology 2016: 31st Annual International Symposium
Mar 6-11, 2016

SAVE THE DATE Cardiovascular Disease Management: A Case-Based Approach, 4th Annual Symposium

SAVE THE DATE Cardiovascular Disease Management: A Case-Based Approach, 4th Annual Symposium
Oct 13-14, 2016

International Academy of Cardiology Annual Scientific Sessions 2016, 21st World Congress on Heart Disease

International Academy of Cardiology Annual Scientific Sessions 2016, 21st World Congress on Heart Disease
Jul 30-Aug 1, 2016

Cardiovascular Disease Management: A Case-Based Approach, 3rd Annual SymposiumTake Evaluation

Cardiovascular Disease Management: A Case-Based Approach, 3rd Annual Symposium
Oct 1-2, 2015

Controversies and Advances in the Treatment of Cardiovascular Disease: The Fifteenth in the SeriesTake Evaluation

Controversies and Advances in the Treatment of Cardiovascular Disease: The Fifteenth in the Series
Nov 19-20, 2015

Controversies & Advances DVD Teaching Program

shop

Controversies & Advances DVD Teaching Program

Interventional Cardiology 2008 DVD Teaching Program

shop

Interventional Cardiology 2008 DVD Teaching Program

Discuss prevention of the escalation of diabetes in the United States at
CDM 2015 in Phoenix!

The Houston Aortic Symposium DVD Set

shop

The Houston Aortic Symposium DVD Set

Frontiers in Cardiovascular Diseases Book

shop
Hazim J. Safi, MD & David D. McPherson, MD

Frontiers in Cardiovascular Diseases Book

Share your thoughts in our Learn From The Leaders Forum!

Lipid experts discuss PCSK9 Inhibitors at CDM 2015

Dr. Heuser is interested to hear what your approach would be with the following patient. Please comment below with your thoughts.

You see a 50 year old gentleman with 3 vessel coronary disease. This non-diabetic, non-smoker really takes care of himself, but in spite of great effort cannot tolerate any statin. Even at normal weight, his LDL still is persistently over 150. His 30%-40% lesions are not severe enough for PCI or surgery, however 10 years ago, you stented his LAD lesion which continues to be patent. His FFR is non-significant in any of these lesions, but more importantly, what can you give him to reduce his…

more»

LATEST SLIDESHOW

RECENT CONTRIBUTORS